COVID-19 pandemic The Singaporean Health Sciences Authority grants interim authorisation for the use of the protein-based Novavax COVID-19 vaccine. Novavax’s Nuvaxovid COVID-19 vaccine granted interim authorisation in Singapore © CNA Sources: CNA
